# About — Get Tirzepatide > Get Tirzepatide is an independent editorial project that publishes summaries of the peer-reviewed research literature on tirzepatide. Not a clinic. Not a vendor. Editorial only. ## Colophon — About the Cabinet **An Editorial Project, Set in Cabinets.** What this site is, what it is not, and how its sourcing methodology actually works. ## What Get Tirzepatide is Get Tirzepatide is an independent editorial project that publishes summaries of the peer-reviewed research literature on tirzepatide. It is not a clinic. It does not employ clinicians. It does not provide medical advice. It does not manufacture, sell, or distribute any product. Its only work is editorial commentary on publicly available science. The site's editorial register — baroque, gallery-curated, cabinet-by-cabinet — is a deliberate choice. Tirzepatide carries one of the densest published trial records of any peptide therapeutic, and the cabinet metaphor is the one that, in the editor's judgement, best matches the weight of that evidence. Each major trial is treated as a framed cabinet piece in a 17th-century presentation gallery: the SURPASS programme, the SURMOUNT programme, SUMMIT, SURMOUNT-OSA, SYNERGY-NASH, and the structural-pharmacology work that underpins all of them. ## What it is not Get Tirzepatide is not a clinic, a pharmacy, a telehealth service, a prescribing platform, a compounding pharmacy, or any vendor of medicines. It does not employ doctors, pharmacists, nurses, or any other clinical staff. It does not maintain a clinical premises. It does not provide consultations. It does not write prescriptions. It does not stock, dispense, or sell tirzepatide in any form. The word 'get' in the domain name is editorial framing — a position the publisher occupies relative to the literature ('get the full record laid out with ceremony') — and is not a claim about the site's services. ## Editorial standards and sourcing methodology Every quantitative claim on this site is cited inline to a primary source. The cabinet's references page lists eighteen folios that, between them, account for every numeric figure printed on the research, dosage, and frequently-asked-questions pages. Where possible the source is a peer-reviewed journal article — The Lancet, the New England Journal of Medicine, JCI Insight, the Proceedings of the National Academy of Sciences, Cardiovascular Diabetology, Diabetes Care, Diabetes Obesity and Metabolism, the Journal of Molecular Neuroscience. Where the source is a compendium reference (the StatPearls tirzepatide entry, for example), that is noted. The editorial bar excludes vendor-published case reports, anecdotal accounts, social-media commentary, and any source that cannot be traced to a primary publication. Real-world-evidence literature is not cited inline because it is derivative of the underlying trial record; readers interested in that body of work are encouraged to consult the relevant systematic reviews. ## A note on the domain modifier The site's domain begins with the word 'get'. That word is editorial framing only. It does not imply that the site will help any reader obtain tirzepatide, write a prescription, fill a prescription, ship a product, or perform any service that resembles a clinical or commercial transaction. Tirzepatide is a regulated prescription medicine; obtaining it requires a prescription from a qualified prescriber and dispensing through a regulated channel. Get Tirzepatide neither prescribes nor dispenses, and the editorial framing of the domain should not be read otherwise. --- Not medical advice. This site does not sell any product and is not affiliated with any vendor or manufacturer.